HNN3.0
Register
Register
Register

Project cooperationUpdated on 20 January 2026

Trustworthy AI development partner

Head of Department - Trustworthy Digital Health at Fraunhofer IKS

Munich, Germany

About

The trustworthy digital health group at Fraunhofer IKS researches and develops AI applications for the healthcare industry, prioritizing trustworthiness, explainability, and robustness.

The group is looking to join a consortium to as an AI development partner for prediction and/or decision support applications in the areas of cardiology and/or women's health.

Topic

  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways
  • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health

Type

  • Partner seeks Consortium/Coordinator

Similar opportunities

  • Project cooperation

    Trustworthy AI development partner

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-03: Advancing research on the prevention, diagnosis, and management of post-infection long-term conditions
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Johannes Karg

    Research Scientist at Fraunhofer IKS

    Munich, Germany

  • Project cooperation

    AI-enabled personalised care pathways for preventive and precision medicine

    • Partner seeks Consortium/Coordinator
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 5: HORIZON-HLTH-2026-01-TOOL-03: Integrating New Approach Methodologies (NAMs) to advance biomedical research and regulatory testing
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Bruno Pires

    Managing Partner at Here Partners

    Lisbon, Portugal

  • Project cooperation

    Cardiovascular disease, imaging, biomarkers, diagnosis and risk stratification, AI

    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-15: Scaling up innovation in cardiovascular health
    • DESTINATION 3: HORIZON-HLTH-2026-01-DISEASE-11: Understanding of sex and/or gender-specific mechanisms of cardiovascular diseases: determinants, risk factors and pathways

    Gudrun Feuchtner

    Professor, Cardiovascular Imaging, MD, MBA at Innsbruck Medical University

    Innsbruck, Austria